MétaCan
Menu
Back to cohort
Record W4417030949 · doi:10.1136/bmjopen-2025-101588

Assessing the feasibility of a platform trial for Gram negative bloodstream infections: results from the vanguard phase of BALANCE+

2025· article· en· W4417030949 on OpenAlexafffundabout
Nick Daneman, Jennie Johnstone, Todd C. Lee, Derek R. MacFadden, Emily G. McDonald, Susan C. Morpeth, Sean Wei Xiang Ong, David L. Paterson, Ruxandra Pinto, Asgar Rishu, Benjamin A. Rogers, Dafna Yahav, Bryan Coburn, Peter Daley, Pavani Das, Kirsten M. Fiest, Aidan Findlater, Christopher Kandel, Archana Malavade, Jeff Powis, Ranjani Somayaji, Robert Fowler

Bibliographic record

VenueBMJ Open · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBacterial Identification and Susceptibility Testing
Canadian institutionsNiagara Health SystemUniversity of CalgaryMemorial University of NewfoundlandUniversity Health NetworkHealth Sciences CentreOttawa HospitalMcGill University Health CentreUniversity of OttawaNorth York General HospitalSunnybrook Health Science CentreSinai Health SystemToronto East General HospitalUniversity of Toronto
FundersCanadian Institutes of Health ResearchClinical Trials Fund, Canadian Institutes of Health Research
KeywordsVanguardPhase (matter)GramBloodstream infectionMEDLINE

Abstract

fetched live from OpenAlex

OBJECTIVES: Gram negative bloodstream infections (GN BSI) are a leading cause of mortality worldwide, and antibiotic treatment approaches remain understudied. BALANCE+ is a perpetual Bayesian adaptive platform trial to test multiple treatment questions for hospitalised patients with GN BSI. The vanguard phase objective was to test the feasibility of the main trial. DESIGN: Adaptive platform trial with five initial domains of investigation, each with open label 1:1 randomisation. SETTING: Ten hospitals across four Canadian provinces. PARTICIPANTS: Individuals admitted to hospital with blood cultures yielding Gram negative bacteria. INTERVENTIONS: The five initial domains of investigation included: antibiotic de-escalation versus no de-escalation; oral transition to beta-lactam versus non-beta-lactam treatment; routine versus no routine follow-up blood cultures (FUBCs); central vascular catheter replacement versus retention; and, ceftriaxone versus carbapenem treatment for low risk AmpC organisms. PRIMARY OUTCOME MEASURES: Domain-specific recruitment rates and protocol adherence. RESULTS: During the vanguard phase, 719 patients were screened, of whom 563 (78.3%) were eligible, with 179 (31.8%) enrolled into the platform. The platform recruitment rate was 1.37 patients/site-week. Recruitment varied by domain: routine versus no FUBC domain 1.23 patients/site-week; oral beta-lactam versus non-beta-lactam domain 0.48; de-escalation versus no de-escalation domain 0.28; low risk AmpC domain 0.02; catheter replacement versus retention domain 0.01. Domain specific protocol adherence rates were 145/158 (91.8%) for routine versus no routine FUBC, 53/60 (88.3%) for oral beta-lactam versus non-beta-lactam, 26/33 (78.8%) for de-escalation versus no de-escalation, 3/3 (100%) for low risk AmpC, and 0/1 (0%) for line replacement versus retention. There was complete ascertainment of all study outcomes in hospital 170/170 (100%) and near complete ascertainment at 90 days 162/170 (95.3%). CONCLUSIONS: The vanguard phase demonstrated overall trial feasibility by recruitment rate and protocol adherence, with differences across interventions, leading to a transition to the main BALANCE+ platform trial with minimal protocol modifications. TRIAL REGISTRATION NUMBER: NCT05893147.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.182
Threshold uncertainty score0.690

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.178
GPT teacher head0.491
Teacher spread0.314 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2025
Admission routes3
Has abstractyes

Explore more

Same venueBMJ OpenSame topicBacterial Identification and Susceptibility TestingFrench-language works237,207